Photolitec

About:

Photolitec develops photosensitizing compounds for image-guided photodynamic therapy.

Website: http://photolitec.org

Top Investors: AMI Organics

Description:

A spin-off of Roswell Park Cancer Institute (RPCI), Photolitec is a new life-sciences company developing photosensitizing compounds for image-guided photodynamic therapy (PDT). PDT is an innovative cancer treatment pioneered at RPCI's Photodynamic Therapy Center. The compounds that Photolitec is working to commercialize were developed primarily by Ravindra Pandey, Ph.D. while at RPCI. Dr. Pandey is a Distinguished Member of the PDT Center and Director of Pharmaceutical Chemistry at RPCI, and is the founder and Chief Scientific Officer of Photolitec.